CD274 and melanoma: Consequently, tumor cells proliferate by evading T-cell-mediated killing, contributing to the progression of melanoma (61) (62).PD-1/PD-L1 inhibitors bind to PD-1 or PD-L1, respectively, blocking the interaction between these two proteins.